TD Cowen analyst Daniel Brennan maintained a Buy rating on GeneDx Holdings (WGS – Research Report) today and set a price target of $118.00. The ...

GeneDx (NASDAQ:WGS) shares maintained their ground following a reiteration of a Hold rating and a $75.00 price target by Jefferies analysts. According to InvestingPro data, analyst targets for the ...

Adds analyst comment. GeneDX (NASDAQ:WGS) fell 4% after a short report from Grizzly Research on the genetic testing company. Grizzly Research disclosed that it's short shares of GeneDX (NASDAQ:WGS).

The short report out Wednesday morning on GeneDx (WGS) by Grizzly Research alleging that the company utilizes an illegal code-stacking scheme ...

In 2022, before changing its name from Sema4 to GeneDx, the company had a dispute with UnitedHealthcare, which resulted in a ...

Learn more about whether The Ensign Group, Inc. or GeneDx Holdings Corp. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Clover Health Investments, Corp. or GeneDx Holdings Corp. is a better investment based on AAII's A+ ...

PFG Investments LLC bought a new position in GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The firm bought 3,274 shares of ...

While Russell 2000 lags major indexes, Dave, GeneDx, Root lead small-cap stocks with massive gains. Which small cap stocks to ...

Strong government Investments and Precision medicine Propel Growth in Sanger Sequencing Market, Expected to Quadruple Its Size Over the Next Decade Akash Anand SNS Insider Pvt. Ltd 415-230-0044 email ...

Nisa Investment Advisors LLC grew its position in shares of GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) by 147,085.3% ...